How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Mixed outlook for Swift Haulage earnings potential
Gold and silver jump to record highs on Greenland tariff threats
Japan bonds slump as food tax cut talk adds to election risk
Lianson Fleet set for improving earnings visibility
Advance GDP signals stronger end to 2025
Growing market liquidity poised to buoy Nestle�
Cypark aims for stronger recurring income stream
Recovery in glove sector ongoing but threats linger
EU weaponising US assets a risk, Deutsche Bank’s Saravelos says
Iran’s real oil risk is labour strikes, not bombs

Others Also Read